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Abstract 24 
Introduction Approximately 30% of all outpatient antimicrobials are inappropriately prescribed. 25 
Currently, antimicrobial prescribing patterns in ED are not well described. Determining 26 
inappropriate antimicrobial prescribing patterns and opportunity for interventions by antimicrobial 27 
stewardship programs (ASP) are needed. 28 
Methods A retrospective chart review was performed among a random sample of non-admitted, 29 
adult patients that received an antimicrobial prescription in the ED from January 1, 2015 to 30 
December 31, 2015. Appropriateness was measured using the Medication Appropriateness Index 31 
(MAI), and was based on provider adherence to local guidelines. Additional information collected 32 
included patient characteristics, initial diagnoses, and other chronic medication use. 33 
Results Of 1,579 ED antibiotic prescriptions in 2015, we reviewed a total of 159 (10.1%) 34 
prescription records. The most frequently prescribed antimicrobial classes included penicillins 35 
(22.6%), macrolides (20.8%), cephalosporins (17.6%), and fluoroquinolones (17.0%). The most 36 
common indications for antibiotics were bronchitis or upper respiratory tract infection (URTI) 37 
(35.1%), followed by skin and soft tissue infection (SSTI) (25.0%), both of which were the most 38 
common reason for unnecessary prescribing (28.9% of bronchitis/URTIs, 25.6% of SSTIs). Of 39 
the antimicrobial prescriptions reviewed, 39% met criteria for inappropriateness. Among 78 40 
prescriptions with a consensus on appropriate indications, 13.8% had inappropriate dosing, 41 
duration, or expense. 42 
Conclusion Consistent with national outpatient prescribing, inappropriate antibiotic prescribing 43 
in the ED occurred in 39% of cases with the highest rates observed among patients with bronchitis, 44 
URTI, and SSTI. Antimicrobial stewardship programs may benefit by focusing on initiatives for 45 
these conditions among ED patients. Moreover, creation of local guideline pocketbooks for these 46 
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and other conditions may serve to improve prescribing practices and meet the Core Elements of 47 
Outpatient Stewardship recommended by the Centers for Disease Control and Prevention. 48 
 49 
Keywords: Antimicrobial, antimicrobial stewardship, emergency department 50 
 51 
  52 
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Background 53 
Overuse of antimicrobials is a major driver of antimicrobial resistance which threatens the health 54 
of people all over the world [1, 2]. On May 20th, 2017, antimicrobial resistance was recognized 55 
and discussed at the Group of Twenty (G20) Summit by leaders from around the world. Together 56 
with the World Health Organization, World Organization for Animal Health, and Food and 57 
Agriculture Organization of the United Nations, the G20 is preparing a global report with three 58 
recommendations: promote conservation of antimicrobials, optimize utilization as underuse, like 59 
overuse, can contribute to antimicrobial resistance, and invest in innovations that can help bring 60 
new antimicrobials, vaccines, and diagnostics to market [3]. Consistent with the first two 61 
recommendations, antimicrobial stewardship programs (ASPs) have improved antimicrobial use 62 
in hospitals through those interventions [4]. However, nearly two-thirds of antibiotic expenditures 63 
occur in the outpatient setting, indicating an important area of need for antimicrobial stewardship 64 
(AMS) [5, 6]. 65 
 66 
To improve antimicrobial use in outpatient settings, the Centers for Disease Control and 67 
Prevention (CDC) recently released the Core Elements of Outpatient Stewardship [6]. These 68 
recommendations include four elements: commitment to improving antibiotic prescribing and 69 
patient safety, implementation of at least one policy or practice, tracking and reporting 70 
antimicrobial prescribing practices, and providing education and expertise to clinicians and 71 
patients on antimicrobial prescribing. These core elements are timely as calls to action for AMS 72 
targeting emergency departments (ED) as part of the outpatient setting have gained interest [7, 8]. 73 
Prior to addressing the Core Elements of Outpatient Stewardship individually, the CDC 74 
recommends identifying high priority indications (e.g. respiratory infections) for targeted 75 
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intervention. Overall, 1/3 of antibiotics in the outpatient setting, including EDs and outpatient 76 
clinics, are inappropriately prescribed with respiratory tract infections attributing to the majority 77 
of inappropriate prescriptions, yielding a significant area of opportunity for AMS [9, 10]. 78 
However, overall rates of inappropriate prescribing specific to ED settings are lacking in the US. 79 
Therefore, the objective of this study was to determine rates of inappropriate antimicrobial use and 80 
define specific areas of opportunity for AMS interventions in the ED. 81 
 82 
Methods 83 
Setting and Patients 84 
The Providence Veterans Affairs Medical Center (PVAMC) is a 119-bed teaching hospital located 85 
in Providence, Rhode Island. Patients included in this period prevalence study were a randomly 86 
selected 10% sample of non-admitted patients 18 years of age or older, who were prescribed an 87 
antimicrobial medication in the PVAMC ED and filled at the PVAMC pharmacy from January 1, 88 
2015 to December 31, 2015. In 2012, the PVAMC implemented an ASP, in which the infectious 89 
diseases pharmacy fellows provide prospective audit and feedback for admitted patients [11]. 90 
However, ED patients were not routinely monitored by the ASP during this study period. 91 
Moreover, the ASP distributed an antimicrobial guidebook, but no specific interventions or 92 
education had been provided to the emergency department on the use of the local guidelines before 93 
or during this period.  94 
 95 
Data Collection and Assessment 96 
Data collection was performed by a clinical pharmacist and an internal medicine physician. Both 97 
clinicians had complete access to the electronic medical records of the included patients. Specific 98 
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data collected included: patient demographics, encounter infectious diagnosis, temperature, white 99 
blood cell count, antimicrobial prescribed (dose, route, duration), concomitant chronic 100 
medications, and appropriateness of antibiotic prescribing based on chart assessment. Both the 101 
clinical pharmacist and physician retrospectively assessed the appropriateness of antibiotic therapy 102 
prescribed based on the documented diagnosis received in the ED for each patient.  103 
 104 
Appropriateness was measured using the Medication Appropriateness Index (MAI) [12]. The MAI 105 
is a validated tool that assesses the appropriateness of 10 different areas of medication prescribing: 106 
indication, effectiveness, dosage (based on indication and renal function), directions, practicality, 107 
drug-drug interactions, drug-disease interactions, duplication, duration, and expensiveness [13, 108 
14]. For every prescribed medication, the reviewers answered each of the 10 questions in the MAI 109 
with either A (appropriate), B (not clearly appropriate), or C (inappropriate). Assessments on the 110 
appropriateness of therapy were made according to local antibiotic use guidelines summarized in 111 
a guidebook tool (http://web.uri.edu/antimicrobial-stewardship/) which was derived from national 112 
practice guidelines endorsed by the Infectious Diseases Society of America (IDSA) and/or CDC. 113 
Study data were collected and managed using REDCap electronic data capture tools hosted within 114 
the VA [15].  115 
 116 
Compliance with ethics guidelines  117 
This study was reviewed and approved by the Institutional Review Board and Research and 118 
Development Committee of the Providence Veterans Affairs Medical Center. This article does not 119 
contain any new studies with human or animal subjects performed by any of the authors. 120 
 121 
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Data Analysis 122 
Descriptive statistics were used for patient characteristics, clinical presentation including 123 
infectious diagnosis, characteristics of prescribed antibiotic (dose, duration, etc.), and MAI results. 124 
MAI responses were categorized as appropriate (appropriate) and inappropriate (inappropriate or 125 
not clearly appropriate) [16]. In calculating inappropriate prescribing rates, for a prescription to be 126 
defined as inappropriate, it had to be categorized as such by consensus between the clinical 127 
pharmacist and internal medicine physician. Kappa statistics for interrater reliability were 128 
calculated for the overall MAI, each MAI category, and by infection type [17, 18].  129 
 130 
Results 131 
Of 1,579 ED-associated antibiotic prescriptions in 2015, we reviewed a total of 159 (10.1%) 132 
prescription records for 148 patients, excluding 2 patients who were subsequently admitted during 133 
the same visit. Patient characteristics and prescribing indications can be found in Table 1. The 134 
median age was 60 and most patients were male (91.2%). Concomitant chronic medication use 135 
was common (median 8, interquartile range 3-13). The most common indications for antibiotics 136 
were bronchitis or upper respiratory tract infection (URTI, 35.1%), followed by skin and soft tissue 137 
infection (SSTI, 25.0%). As reflected in Table 2, frequently prescribed antibiotics included 138 
penicillins (22.6%), macrolides (20.8%), cephalosporins (17.6%), and fluoroquinolones (17.0%).  139 
 140 
A summary of inappropriate prescribing based on MAI criteria is shown in Table 3. Thirty-nine 141 
percent of antimicrobial prescriptions were classified as inappropriate. Inappropriate prescribing 142 
varied by indication: bronchitis/URTI (15/52, 28.9%), SSTI (10/39, 25.6%), intra-abdominal 143 
infections (15.0%; 3/20), community-acquired pneumonia (CAP, 3/9, 33.3%), urinary tract 144 
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infection (UTI, 2/8, 25.0%), and other conditions (4/14, 28.6%). Of the 79 (49.7.8%) prescriptions 145 
with a consensus on appropriate indication, inappropriate prescribing was noted among 13.8% of 146 
prescriptions with regards to dose, duration, or expense while the other MAI categories reflected 147 
no inappropriate prescribing based on reviewer consensus. CAP and UTI dosing were found to be 148 
inappropriate in 11.1% and 12.5% of cases, respectively. Inappropriate durations were found in 149 
6.0% of bronchitis/URTI, 7.7% of SSTI, and 5.0% of intra-abdominal infections. Excessive 150 
expense was noted in 11.1% of CAP, and only 2% of bronchitis/URTI.  151 
 152 
Overall, interrater reliability of the MAI was high (k=0.90). The kappa statistics for indication, 153 
dose, and duration were 0.46, 0.47, and 0.26, respectively. Though other MAI categories had high 154 
positive agreement for appropriateness (median 85, IQR 79-98), kappa statistics could not be 155 
calculated for these MAI categories due to the lack of negative agreement (determined as 156 
inappropriate by both reviewers). Kappa scores by indication were also high, with a median of 157 
0.82 (IQR 0.58 to 0.91).  158 
 159 
Discussion 160 
The present study reflects the first ED inappropriate prescribing assessment reported in the US, 161 
with 39% of prescribing found to be inappropriate as defined by the Medication Appropriateness 162 
Index and local guidelines. The two most common indications, SSTI and bronchitis/URTI also had 163 
the highest rates of inappropriate prescribing (25.6% and 28.9%) aside from CAP where ~1/3 of 164 
antibiotics were not indicated based on diagnostic criteria from a chart review. These results are 165 
consistent CDC data which found ~1/3 of antibiotic prescriptions in the outpatient setting, 166 
including outpatient clinics and EDs, as being inappropriate [9].  167 
9 
 
 168 
Similar to studies from outpatient clinic settings, we found an opportunity for AMS among patients 169 
with a diagnosis of bronchitis or URTI patients with 28.9% of prescribing being inappropriate 170 
based on indication [9, 10]. In our older population of Veterans, the prevalence of chronic 171 
obstructive pulmonary disease (COPD) is more than double that of the general US population [19, 172 
20]. Therefore, many of these patients may have had a history of COPD, and thus component of 173 
COPD exacerbation requiring antibiotics. Our local guidance, concordant with national guidelines 174 
for bronchitis and URTIs, infrequently recommends antibiotics since >90% of patients presenting 175 
with a new onset cough for outpatient treatment have a virus [21].  176 
 177 
To assist in diagnostic uncertainty for respiratory indications, rapid diagnostic testing, both 178 
procalcitonin and respiratory viral panels, have been shown to help in decreasing inappropriate 179 
antibiotic use among patients presenting with respiratory illnesses with possible infectious 180 
etiologies [22, 23]. However, these technologies may be suboptimal in decreasing inappropriate 181 
antibiotic use unless there is education and AMS guidance along with audit and feedback [24]. 182 
Future efforts should focus on how to optimize implementation of diagnostic testing within the ED 183 
to increase appropriate use of antibiotics in patients with respiratory tract infections. Clinician 184 
education has also been shown to be an effective intervention modality for decreasing 185 
antimicrobial use in adults with acute respiratory infections treated in EDs [25].  186 
 187 
Another important area of opportunity identified for improved prescribing was with SSTIs. We 188 
found 25.6% of prescribing for SSTIs was inappropriate based on indication. Current national 189 
guidelines recommend against the use of antibiotics for uncomplicated skin abscesses which have 190 
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undergone incision and drainage, yet this practice remains common [26, 27]. A study of the 191 
National Hospital Ambulatory Medical Care Survey (NHAMCS) from 2007-2010 found that 87% 192 
of visits for abscesses which had incision and drainage were still prescribed antibiotics [27]. 193 
Adaptation of and education on ED-specific national guidelines may encourage ED providers to 194 
execute more judicious use [28]. 195 
 196 
While comprehensive assessments of inappropriate antibiotic prescriptions in the ED have not 197 
been previously reported in the US, a recent study in France found that 59.9% (455/760) of 198 
prescriptions in the ED were inappropriate [29]. This was higher than our observed 39% which 199 
may be due to differences in patient populations, as well as national and local treatment guidelines. 200 
Similar to our study however, they found high rates of inappropriate prescribing for respiratory 201 
tract infections (46.5%), SSTIs (71.2%), and UTIs (38.4%). We also observed high inappropriate 202 
prescribing for UTIs (37.5%). Education on optimal empiric treatments given high resistance to 203 
therapies like fluoroquinolones has been shown to improve empiric prescribing [30, 31]. 204 
 205 
To date, there has been a single study reporting on a comprehensive AMS initiative in the ED [32]. 206 
This was a single center study at a 497-bed tertiary university hospital in France with about 35,000 207 
ED visits per year. An intervention bundle was employed consisting of a 0.2 infectious diseases 208 
(ID) physician full-time equivalent for advising during business hours, educating staff every 6 209 
months on stewardship principles, creating a treatment guideline pocketbook, appointing an ED 210 
antimicrobial champion to attend daily staff meetings and promote optimal antimicrobial use, and 211 
reviewing ED antibiotic prescribing and culture results twice weekly by the ID physician. 212 
Antimicrobials were prescribed in 769 visits during the pre-implementation period and 580 visits 213 
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in the post-implementation period. Prescriptions were not compliant with guidelines in 62.9% of 214 
the pre- and 46.7% of the post-implementation visits (p<0.001). Non-indicated prescriptions 215 
decreased by 8.2% (<0.001), while prescriptions with excessive duration decreased by 2.2% (non-216 
significant). The bundled intervention in this study consisted of various stewardship activities 217 
which would be useful to address inappropriate antimicrobial prescribing in an ED. These 218 
activities are also supported by a systematic review of AMS in outpatient settings [33]. 219 
 220 
Measuring inappropriate rates of antimicrobial prescribing is important, yet challenging [34]. A 221 
recent study evaluating antimicrobial appropriateness with computerized case vignettes, as 222 
reviewed by two infectious diseases physicians, demonstrated a kappa of 0.01 after initial 223 
independent review, 0.34 after discussion of case disagreements, and 0.72 after uniform 224 
application of institutional guideline criteria. In our initial pilot study, 50 randomly selected 225 
patients were evaluated using national guidelines without a summary tool or local guidelines and 226 
resulted in a lower overall interrater reliability (k=0.30), hence the use of local guidelines 227 
substantially improved our interrater reliability (k=0.90). The importance of assessing antibiotic 228 
appropriateness using local guidelines to decrease subjectivity and increase reproducibility of 229 
assessments has been suggested elsewhere [35]. In fact, this is part of the CDC core elements for 230 
outpatient stewardship’s initial steps: establishing standards for antibiotic prescribing [6]. They 231 
recommend to consider adapting national guidelines to establish clear expectations for appropriate 232 
antibiotic prescribing. 233 
 234 
There are several limitations to this study. Our study was a single center in a VA ED. Moreover, 235 
given our sample size, outcomes of inappropriate prescribing were not assessed. Future 236 
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comprehensive assessments of inappropriate antibiotic prescribing in the ED should be evaluated 237 
in community hospital settings to assess differences among non-Veteran populations and should 238 
attempt to evaluate outcomes of inappropriate prescribing. Due to data collection limitations, this 239 
study did not capture patients who did not fill their prescriptions at the PVAMC pharmacy. 240 
Additionally, we only evaluated patients that were prescribed an antibiotic, indicating a potential 241 
selection bias. The use of the kappa statistic limited our ability to calculate interrater reliability 242 
for some MAI categories due to a lack of negative agreement (determined as inappropriate by 243 
both reviewers), especially when there were high rates of appropriateness. We evaluated only 244 
empiric prescribing and did not evaluate culture results, therefore our inappropriate rates of 245 
antibiotic use are likely conservative. However, extensive literature on the value of AMS in 246 
culture result follow-up reflects both the need and benefit of AMS in optimizing definitive 247 
therapy and discontinuation of therapy in the absence of organism growth [36-40]. While our 248 
local guidelines provided objective assessment criteria for many indications, they were not 249 
exhaustive, and therefore, decisions on certain indications relied more heavily on clinical 250 
judgement.  251 
 252 
Conclusion 253 
Consistent with national outpatient prescribing, inappropriate prescribing was identified in 39% of 254 
antibiotic prescriptions in the ED with the highest rates among patients with bronchitis, URTI, and 255 
SSTI. ASPs may benefit by focusing on initiatives for these conditions in the ED setting. 256 
Moreover, creation of local guideline pocketbooks may improve prescribing practices, with these 257 
activities together meeting the CDC recommended Core Elements of Outpatient Stewardship. 258 
 259 
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Table 1. Patient characteristics 405 
Characteristics N = 148 
Age (years), median (IQR) 60 (44-69) 
Male 135 (91.2%) 
White 125 (84.5%) 
Temperature (C), median (IQR)  36.7 (36.5-37.0) 
White blood cells 
(measurement), median (IQR) 
(n=64) 
8.4 (6.5-11.2) 
Concomitant medications, 
median (IQR) 
8 (3-13) 
Indication  
Bronchitis or URTI 52 (35.1%) 
CAP 8 (5.4%) 
COPD 5 (3.4%) 
Flu 1 (0.7%) 
Intra-abdominal 12 (8.1%) 
Other 14 (9.5%) 
Prophylaxis 7 (4.7%) 
SSTI 37 (25.0%) 
UTI 8 (5.4%) 
  406 
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Table 2. Antimicrobials prescribed 407 
Drug class N=159 
Antiviral 8 (5.0%) 
Clindamycin 4 (2.5%) 
Cephalosporin 28 (17.6%) 
Fluoroquinolone 27 (17.0%) 
Macrolide 33 (20.8%) 
Metronidazole 8 (5.0%) 
Penicillins 36 (22.6%) 
Sulfonamide 4 (2.5%) 
Other 11 (6.9%) 
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Table 3: Inappropriate prescriptions by MAI category 410 
MAI category no. (%) 
Indication 40 (25.2) 
Effectiveness 0 (0) 
Dosage 2 (1.3) 
Correct directions 0 (0) 
Drug-drug interaction 0 (0) 
Drug-disease 
interaction 
0 (0) 
Practical directions 0 (0) 
Expense 12 (7.5) 
Duplication 0 (0) 
Duration 8 (5.0) 
Total 62 (39.0) 
MAI, medication appropriateness index 411 
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